FDA 483 - Pharmaceutics International Inc - March 24, 2017
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Pharmaceutics International Inc. in Hunt Valley, MD, was cited for significant quality system deficiencies during an FDA inspection. Observations included inadequate investigations into product failures and discrepancies, a backlog of unaddressed customer complaints and quality events, and a failure to complete annual product reviews. Additionally, the firm lacked appropriate controls over electronic records for change controls and work orders, indicating a systemic issue with data integrity and quality oversight.
ID · b07bb327-5fc1-42c1-84cd-82046c777127